David Altshuler
2017
In 2017, David Altshuler earned a total compensation of $5.7M as EVP & Chief Scientific Officer at Vertex Pharmaceuticals, a 20% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $638,250 |
|---|---|
| Option Awards | $1,332,316 |
| Salary | $596,731 |
| Stock Awards | $3,150,020 |
| Other | $13,110 |
| Total | $5,730,427 |
Altshuler received $3.2M in stock awards, accounting for 55% of the total pay in 2017.
Altshuler also received $638.3K in non-equity incentive plan, $1.3M in option awards, $596.7K in salary and $13.1K in other compensation.
Rankings
In 2017, David Altshuler's compensation ranked 1,570th out of 14,666 executives tracked by ExecPay. In other words, Altshuler earned more than 89.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,570 out of 14,666 | 89th |
Division Manufacturing | 526 out of 5,770 | 91st |
Major group Chemicals And Allied Products | 139 out of 2,074 | 93rd |
Industry group Drugs | 101 out of 1,730 | 94th |
Industry Pharmaceutical Preparations | 80 out of 1,329 | 94th |
Source: SEC filing on April 17, 2018.
Altshuler's colleagues
We found six more compensation records of executives who worked with David Altshuler at Vertex Pharmaceuticals in 2017.
2017
Jeffrey Leiden
Vertex Pharmaceuticals
Chief Executive Officer
2017
Michael Parini
Vertex Pharmaceuticals
EVP & Chief Legal and Administrative Officer
2017
Ian Smith
Vertex Pharmaceuticals
Chief Operating Officer
2017
Amit Sachdev
Vertex Pharmaceuticals
EVP & Chief Regulatory Officer
2017
Stuart Arbuckle
Vertex Pharmaceuticals
EVP & Chief Commercial Officer
2017
Thomas Graney
Vertex Pharmaceuticals